E

Entos, Inc

57 employees

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Basic info

Industry

biotechnology research

Sectors

Artificial Intelligence
pharmaceuticals
quantum mechanics
polymers
artificial intelligence
materials
Software
sustainability
chemistry
drug discovery
catalysis
Therapeutics
biochemistry
molecular simulation
energy
Machine Learning
machine learning
batteries

Date founded

2019

Funding rounds raised

Total raised

$53M

from 6 investors over 6 rounds

E

Entos, Inc raised undisclosed on October 4, 2022

Investors: Hedonova

E

Entos, Inc raised $53M on July 14, 2021

Investors: FreeFlow App, Coatue Management, Nexus Venture Partners, Catalio Capital Management and OrbiMed Advisors

FAQ